screening trial

screening trial

A clinical trial conducted to detect persons with an early, mild or an asymptomatic state of a disease of interest.
Mentioned in ?
References in periodicals archive ?
Cameron Reynolds, Chief Executive Officer of Volition, commented, "After seven years of hard work, we are happy to announce these excellent early detection interim results from our ongoing front-line screening trial for colorectal cancer.
The clearest change was the age range, which expanded from 55-74 years of age set in 2013 to reflect the age criterion for enrollment in the National Lung Screening Trial (New Engl J Med.
This new analysis, funded by the National Cancer Institute, assessed the differences between the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Minister for Health and Aged Care Sussan Ley today announced details of the Pharmacy Diabetes Screening Trial under the Australian Governments $50 million Pharmacy Trial Program.
Finnish researchers evaluated the incidence of prostate cancer and cardiovascular mortality in men treated with TRT in the Finnish Prostate Cancer Screening Trial (FinRSPC), a population-based study in which the only exclusion criteria was a previous diagnosis of prostate cancer.
However, the National Lung Screening Trial provides evidence that routine low-dose computed tomography (CT) screening can be effective, provided the guidelines are followed strictly and the operative morbidity and mortality is sufficiently low.
RESULTS from the world's biggest ovarian cancer screening trial, involving 10,000 Teesside women, suggests screening could save lives.
A recent screening trial of 5,300 mums at Northwick Park hospital in London led to an 80% drop in cases.
1) The announcement of the National Lung Screening Trial (NLST) results in 2010 and their subsequent publication was a defining moment in the lengthy quest to determine the value of low-dose CT (LDCT) lung cancer screening.
The study included more than 39,000 participants (ages 55 to 74) in a large prostate cancer screening trial who were queried about their hair-loss patterns when they were age 45.
ALCHEMIST reportedly consists of three integrated precision medicine trials that are being implemented through the National Clinical Trials Network (NCTN) of the National Cancer Institute (NCI) - a screening trial and two associated treatment trials.
The study included participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, which enrolled over 155,000 men and women between 1993 and 2001.